| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/26/2007 | WO2007047209A2 Method of measuring hexavalent chromium in electronic components and assemblies |
| 04/26/2007 | WO2007047196A2 Method for monitoring a childbirth process |
| 04/26/2007 | WO2007047097A1 Multiple function bulk acoustic wave liquid property sensor |
| 04/26/2007 | WO2007047046A1 High resolution elastography using two step strain estimation |
| 04/26/2007 | WO2007047029A2 Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb) |
| 04/26/2007 | WO2007046893A2 Methods for generating bioactive assemblies and uses thereof |
| 04/26/2007 | WO2007046882A2 Devices and methods for profiling enzyme substrates |
| 04/26/2007 | WO2007046865A1 Biological indicator |
| 04/26/2007 | WO2007046844A2 System and method for visual representation of a catastrophic event and coordination of response |
| 04/26/2007 | WO2007046834A2 Glp-1 agonists, compositions, methods and uses |
| 04/26/2007 | WO2007046811A2 Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| 04/26/2007 | WO2007046774A1 In vivo fluorescence imaging |
| 04/26/2007 | WO2007046745A1 A method and apparatus for assessing blood concentration of a volatile constituent |
| 04/26/2007 | WO2007046520A1 Method for screening of protein using immobilized puromycin linker |
| 04/26/2007 | WO2007046472A1 Method of measuring polymerization degree of protein |
| 04/26/2007 | WO2007046463A1 Atopic dermatitis marker and technique of using the same |
| 04/26/2007 | WO2007046450A1 Apparatus for monitoring thrombus formation and method of monitoring thrombus formation |
| 04/26/2007 | WO2007046280A1 Freshness sensor |
| 04/26/2007 | WO2007046139A1 Fuel gas moisture monitoring apparatus and method of monitoring fuel gas moisture |
| 04/26/2007 | WO2007046108A2 Methods and kits for analyzing genetic material of a fetus |
| 04/26/2007 | WO2007045996A1 An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| 04/26/2007 | WO2007045927A2 Therapeutic agent |
| 04/26/2007 | WO2007045911A1 Integral membrane protein |
| 04/26/2007 | WO2007045906A1 Rfamide-related peptide precursor proteins and rfamide peptides |
| 04/26/2007 | WO2007045896A1 Diagnostic kits and methods for oesophageal abnormalities |
| 04/26/2007 | WO2007045862A1 Evaluation of the fragrance characteristics of a substance |
| 04/26/2007 | WO2007045799A1 Method for screening a proteasome activity modulating agent and means for carrying out said method |
| 04/26/2007 | WO2007045661A1 Detection or quantification of aggrecan and its fragments |
| 04/26/2007 | WO2007045510A1 Device and process for determining an organic and inorganic fraction of a sample |
| 04/26/2007 | WO2007045481A2 A system and method for the determination of an electrical characteristic of a liquid |
| 04/26/2007 | WO2007045453A1 Method for characterizing the glycosylation of sialoglycoproteins via an isoform number i |
| 04/26/2007 | WO2007045432A2 Srf as a diagnostic and/or therapeutic target for diseases that are associated with neuronal abnormalities |
| 04/26/2007 | WO2007045389A2 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma |
| 04/26/2007 | WO2007027661A3 Human g protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to mcp-1 expression |
| 04/26/2007 | WO2007025100A3 Gas sensors |
| 04/26/2007 | WO2007024272A3 Cartridge with a wheel for sealing the opening |
| 04/26/2007 | WO2007017067A3 Modulators of the melted protein and uses thereof |
| 04/26/2007 | WO2007015878A3 Method for measuring cytopathic effect in cells using electric cell-substrate impedance sensing |
| 04/26/2007 | WO2007008221A3 DETECTION OF PHOSPHORYLATED eIF2α AS A DIAGNOSTIC TEST FOR EFFICIENCY AND SENSITVITY OF TRANSLATION INITIATION INHIBITORS IN THE TREATMENT OF CANCER AND OTHE R PROLIFERATIVE DISEASES |
| 04/26/2007 | WO2007006858A3 Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same |
| 04/26/2007 | WO2007004060A3 Cytokine receptor modulators and uses thereof |
| 04/26/2007 | WO2007003675A3 Experimental neuroinflammation model, method of obtaining same and applications thereof |
| 04/26/2007 | WO2007003344A3 Device for quantitative analysis of a metabolite profile |
| 04/26/2007 | WO2007002081A3 Gfats as modifiers of the axin pathway and methods of use |
| 04/26/2007 | WO2007001081A3 Method , array , apparatus and test system to discriminate individuals |
| 04/26/2007 | WO2006136527A3 Test device comprising a bearing mechanism for test elements |
| 04/26/2007 | WO2006130720A3 Purification, characterization and reconstitution of a ubiquitin e3 ligase |
| 04/26/2007 | WO2006127692A3 Optical microscopy with phototransformable optical labels |
| 04/26/2007 | WO2006123253A3 Device and method of monitoring a patient |
| 04/26/2007 | WO2006122002A3 Multiplex capture of nucleic acids |
| 04/26/2007 | WO2006121422A8 Antibodies against clostridium difficile toxins and uses thereof |
| 04/26/2007 | WO2006117242A3 Method for characterizing the transactivation and transgression activity of glucocorticoid receptor ligands in primary immune cells |
| 04/26/2007 | WO2006116325A8 Multiple-valent opsonophagocytic assay selection panel arrays and uses therefor |
| 04/26/2007 | WO2006113880A3 Intact igfbp-3 as a colon cancer risk factor in patients with inflammatory bowel disease |
| 04/26/2007 | WO2006113720A3 Solid phase immobilization of phospholipids and cofactor proteins via covalent attachment |
| 04/26/2007 | WO2006108583A3 Human marker genes and agents for cardiovascular disorders and artherosclerosi s |
| 04/26/2007 | WO2006108180A3 Thin film coated microwell arrays and methods of making same |
| 04/26/2007 | WO2006107611A3 Detection of an immune response to gdf-8 modulating agents |
| 04/26/2007 | WO2006102979A3 Inflammation markers and combinations thereof as biochemical markers for cardiovascular diseases |
| 04/26/2007 | WO2006089773A3 Method and device for determining the concentration of organically bound halogens |
| 04/26/2007 | WO2006087603A3 Isoelectric particles and uses as electrophoretic tags for multiple analyte detection using capillary isoelectric focusing |
| 04/26/2007 | WO2006086208A3 5-fluoro-uracil immunoassay |
| 04/26/2007 | WO2006083292A3 Microorganism detection using bacteriophage amplification |
| 04/26/2007 | WO2006061130A3 Use of a serum/glucocorticoid-regulated kinase |
| 04/26/2007 | WO2006060188A3 Anti-tenascin monoclonal antibody immunoassays and diagnostic kits |
| 04/26/2007 | WO2006044275A3 Methods for altering surface characteristics of microspheres |
| 04/26/2007 | WO2006044121A3 Methods and apparatus for identifying and diagnosing live eggs using heart rate and embryo motion |
| 04/26/2007 | WO2005069934A3 Peptide identification |
| 04/26/2007 | WO2005051314A3 Iraks as modifiers of branching morphogenesis and methods of use |
| 04/26/2007 | WO2004015061A3 Determination of protein function |
| 04/26/2007 | US20070094049 Method and apparatus for remote health monitoring and providing health related information |
| 04/26/2007 | US20070093969 Molecular nephrotoxicology modeling |
| 04/26/2007 | US20070093968 Selection of Genotyped transfusion donors by cross-matching genotyped recipients |
| 04/26/2007 | US20070093653 siRNA targeting MCL1 |
| 04/26/2007 | US20070093652 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands |
| 04/26/2007 | US20070093536 Target protein of antidiabetic and novel antidiabetic insuful corresponding thereto |
| 04/26/2007 | US20070093445 RNA interference mediating small RNA molecules |
| 04/26/2007 | US20070093436 Drop1, a novel marker for carcinogenesis |
| 04/26/2007 | US20070092978 Target ligand detection |
| 04/26/2007 | US20070092977 Forensic test for human saliva |
| 04/26/2007 | US20070092971 Buffy coat separator float system and method |
| 04/26/2007 | US20070092970 High-throughput screening assay for Na, K-ATPase using atomic absorption spectroscopy |
| 04/26/2007 | US20070092964 Ion detection using a pillar chip |
| 04/26/2007 | US20070092941 PRO1298 polypeptides |
| 04/26/2007 | US20070092939 Human immunodeficiency virus entry inhibitor assay |
| 04/26/2007 | US20070092938 Diagnostics for sars virus |
| 04/26/2007 | US20070092922 Taxol immunoassay |
| 04/26/2007 | US20070092921 Measuring hemoglobin and albumin, which indicate presence of gastric and/or colonic ulcers or bleeding |
| 04/26/2007 | US20070092920 Serum Prolactin Binding Protein in Epithelial Carcinoma |
| 04/26/2007 | US20070092919 Monitoring of liquids for disease-associated materials |
| 04/26/2007 | US20070092918 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer |
| 04/26/2007 | US20070092917 Biomarkers for screening, predicting, and monitoring prostate disease |
| 04/26/2007 | US20070092916 Using concentration of iron regulating polypeptide to detect blood disorders; immunoassay |
| 04/26/2007 | US20070092915 Contacting polysaccharide, glycoprotein or lipid with labeled substrate having binding agent such as lectin, cleaving enzyme or antibody on its surface; |
| 04/26/2007 | US20070092914 Compartmentalised screening by microfluidic control |
| 04/26/2007 | US20070092913 Methods for identifying agents that modulate GPR105 activity |
| 04/26/2007 | US20070092912 Uses of human zven antagonists |
| 04/26/2007 | US20070092911 Methods and compositions for diagnosis and /or prognosis in systemic inflammatory response syndromes |
| 04/26/2007 | US20070092907 Methods of screening compound probes |
| 04/26/2007 | US20070092900 Methods for diagnosing and characterizing breast cancer and susceptibility to breast cancer |